[Note: The MDIC (MenieresInfo.com)
is privately funded and does not solicit
or accept donations.]
Three famous
patients have endorsed donations to the
American Academy of Otolaryngology-Head and Neck Surgery Foundation,
Inc., via SixDegrees.org
"charity badges" at their websites. Note that if one wishes to
restrict donations to research for the purposes of Meniere's Disease (as
opposed to Meniere's Disease together with other ear, nose, and throat
disorders), one should so indicate in the field that says "Designation
(Optional). To designate your donation for a specific fund or
purpose, please enter a description of how you'd like your donation to
be used."
According to its
website, the
American Academy of Otolarygology-Head and Neck Surgery (AAO-HNS) is an
association of medical professionals and is recognized as a professional
association under I.R.C. § 501(c)(6), working for the
best ear, nose, and throat care. The American Academy of
Otolaryngology-Head and Neck Surgery Foundation (AAO-HNS/F) is
recognized as a non-profit, educational organization under I.R.C. §
501(c)(3).
The Foundation is the recipient of donations via the patients' "badges."
Financial information about the Foundation can be found on the website
of Guidestar.org by clicking
here. The information is apparently based on information that
is publicly available from annual IRS Forms 990 (or 990 EZ) filed by the
Foundation.
Note that donations to
organizations recognized under
I.R.C. § 501(c)(3) are deductible on U.S. federal
income tax returns as
charitable
contributions, subject to the usual conditions.
On May 1, 2007, we asked
some questions of Kris Schulz, M.Ph., who is the Senior Director for
Research of the AAO-HNS, about research specifically directed toward
Meniere's Disease. She very promptly provided the following
comprehensive information.
Where we are now with Ménière’s research
Grant and research initiative funding
The
AAO-HNS/F has ~13,000 otolaryngologists worldwide in its membership.
Examples of funded research specific to Ménière's include:
1. A
career development grant entitled "Pilot Study of the Effectiveness
of Famvir in Ménière's Disease" to Jennifer Derebery at the House
Ear Institute, Los Angeles
2.
A resident research grant entitled "Effects of intratympanic
gentamycin on canal cristae" to Iee Ching Wu Anderson at Johns
Hopkins (Single dose intratympanic gentamycin is used to alleviate
vertigo in patients with Ménière's - this study is a basic science
animal model to determine anatomically how well animal data correlates
to human)
Through our Combined Otolaryngology Research
Efforts (CORE) grants program, we – along with a group of sister
societies – have been funding otolaryngology research for over 20 years.
We funded close to ~$500K in research in 2006 and expect to increase
those numbers significantly this year. We received 127 applications and
final decisions are being made now by the societies. We had many
applications that referenced Ménière's Disease, and one pending
application that specifically focused on Ménière's Disease, a resident
research grant in basic science testing vasopressin on vestibular
function in an animal model of Ménière's Disease with the hypothesis
that treatments that block vasopressin receptors will protect against
hearing loss and vertigo, and may prove a useful treatment for the
vestibular symptoms of Meniere's disease.
Contributing to peer reviewed literature
The
AAO-HNS/F has a monthly scientific peer reviewed journal (Otolaryngology
- Head and Neck Surgery). In a search of the last 10 years of the
journal online, there were 395 hits for Ménière's. Ménière's is a
very well published topic. Some recent titles are listed below:
Endolymphatic mastoid shunt versus endolymphatic sac decompression for
Ménière’s disease
Brinson GM, Chen DA, Arriaga MA
Otolaryngology - Head and Neck Surgery- 2007 03 (Vol. 136, Issue 3)
Spontaneous intracranial hypotension mimicking Ménière’s disease
Miller RS, Tami TA, Pensak M
Otolaryngology - Head and Neck Surgery- 2006 10 (Vol. 135, Issue 4)
From
our September 2006 Annual Meeting Program (published in the Journal):
R043: Redox Regulation and Auto Antibodies in Ménière's Disease
Hayashi K, Kobayashi R, Matsumoto T, Ogawa K
Otolaryngology - Head and Neck Surgery- 2006 08 (Vol. 135, Issue 2
(Supplement))
P113: High Resolution MRI in Patients with Ménière's Disease
Silver RD, Bachuwar A, Rimell FL, Levine SC
Otolaryngology - Head and Neck Surgery- 2006 08 (Vol. 135, Issue 2
(Supplement))
P136: The True Story of Ménière's Disease
Paco JCLS, Garcia CS, Carmo DO
Otolaryngology - Head and Neck Surgery- 2006 08 (Vol. 135, Issue 2
(Supplement))
Where we are hoping to go with Ménière’s research
Otolaryngology is a broad discipline and the AAO-HNS is an organization
that represents all otolaryngologists. In terms of focusing research,
however, we are open to focusing research efforts and dollars to
specific conditions when it’s warranted. We contract with the Duke
Clinical Research Institute to perform clinical trials on very specific
topics. In a nutshell, we are happy to promote research in a specific
target population as long as the guidelines are consistent with our
organization’s mission and vision.
What will we do with the funding we get through six degrees
badges
At present, our top goal is for badges to raise awareness
of any otolaryngology condition for which we can find passionate patient
advocates. Ménière’s is one of those conditions – in fact, Ménière’s had
the biggest patient presence in online communities. This attempt to
raise awareness and funding is in its infancy. But, in terms of what we
will do with funding and how it will be earmarked, while all funding
through badges will go to the AAO-HNS Foundation, we will be keeping
track of what funding comes through which badges and internally keep
track of the clinical topics and the dollar amount raised and in good
faith develop mechanisms that give back to the clinical topic that
promoted the interest and funding. We are a small foundation, but
one that is dedicated to improving and enhancing research in this
important field, with a patient population that lives with such
debilitating conditions.